USAID Global Accelerator to End TB

A group of women in India raise their hands to end tuberculosis.
USAID’s investments are most successful when they are coupled and aligned with strong commitments from other governments and partners. To accelerate action, USAID has announced an innovative model, “The Global Accelerator to End Tuberculosis.” The Accelerator will leverage additional resources from countries, private sector partners, and local organizations to meet the global target of treating 40 million people by 2022.
From 2018-2022, 40 million people will be on treatment for TB.

ACCELERATING ACTION ON TB TOWARDS ACHIEVING 40X22

USAID leads the U.S. Government’s global tuberculosis (TB) efforts, working with agencies and partners around the world to reach every person with TB, cure those in need of treatment, and prevent the spread of new infections.

In September 2018, the United Nations General Assembly High Level Meeting (UNHLM) on TB set the stage for high-level attention and action on TB. This meeting established the ambitious target of diagnosing and enrolling an additional 40 million people on TB treatment by 2022 (commonly referred to as 40x22), with a focus on countries with the highest TB burden, and enrolling 30 million on TB preventive therapy (commonly referred to as 30x22).

THE GLOBAL ACCELERATOR TO END TB

To help countries achieve these targets, at the 2018 UNHLM, USAID Administrator Mark Green announced the Agency’s new TB business model – the Global Accelerator to End Tuberculosis. The Accelerator is designed to increase investments from the public and private sectors to end the TB epidemic, while simultaneously building local commitment and capacity to achieve the goals set forth at the UNHLM. It focuses on countries with high burdens of TB where the Agency can align with local communities and partners to deliver performance-based results toward the global target.

The Accelerator aims to reach this target by: deploying more focused technical expertise to increase TB and MDR-TB diagnosis and treatment, especially to support the ministries of health; strengthening the involvement and response to TB of local organizations, including community and faith-based groups; accelerating the transition of sustainable funding and management of TB programs to governments and their partners; and improving coordination with other health programs.

The Accelerator ensures that USAID is fighting to end TB efficiently and effectively while focusing on locally-generated solutions that tailor the Agency’s TB response and combat stigma and discrimination. Since the launch of the Accelerator, USAID has shifted its business model to develop programs and strategies to achieve a more accountable, responsible, and inclusive TB response by countries to meet the UNHLM commitments and targets. USAID is improving our partnership with the countries by mutually agreeing on priority areas of collaboration with all stakeholders at all levels. The approach has focused on three key areas including joint TB partnership statements, enhanced and focused technical support, and increased ownership and engagement of local partners.

Last updated: November 04, 2019

Share This Page